POSTN and inflammatory breast carcinoma: Immunostaining data of periostin were available in 26/26 (100%) cases of normal breast tissue, 74/76 (97.4%) cases of DCIS, and 189/198 (95.5%) cases of IBC, after the exclusion of non-informative and missing cores (Fig 2).